






Safety skin puncture lancets are medical devices used to obtain capillary blood samples for diagnostic testing. These devices are primarily used by individuals managing chronic conditions such as diabetes and healthcare professionals for various blood tests. Designed for single-use, safety lancets minimize the risk of cross-contamination and infections, making them an essential tool in both home and clinical settings.
The global safety skin puncture lancet market was valued at approximately USD 586 million in 2024 and is projected to reach USD 956.91 million by 2032, growing at a CAGR of 5.60% during the forecast period. CAGR of 5.60%
• Safety Lancets with Needle
• Safety Lancets with Blade
• Roche
• BD (Becton, Dickinson and Company)
• Ascensia
• Lifescan
• B. Braun
• Terumo
• Nipro
• Including or Excluding key companies relevant to your analysis.